SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001104659-21-041312
Filing Date
2021-03-25
Accepted
2021-03-25 11:05:08
Documents
1
Effectiveness Date
2021-03-25
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6426
  Complete submission text file 0001104659-21-041312.txt   7478
Mailing Address 53 MAIN STREET SUITE 206 CONCORD MA 01742
Business Address 53 MAIN STREET SUITE 206 CONCORD MA 01742 6173887171
Lennham Pharmaceuticals, Inc. (Filer) CIK: 0001853301 (see all company filings)

IRS No.: 833016066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-393490 | Film No.: 21770899